Get started
Author

Andrew M. Peseski

Observed names: Andrew Michael Peseski, Andrew Peseski
Institution: Duke University
ORCID: 0000-0002-5114-611X
Observed ORCID: 0000-0002-5114-611X
OpenAlex ID: A5065639645
Management of fever and neutropenia in the adult patient with acute myeloid leukemia
2020 · Andrew M. Peseski, Mitchell McClean, et al. · Expert Review of Anti-infective Therapy · 40
Case Report: Candida dubliniensis as a Cause of Chronic Meningitis
2020 · Madiha Tahir, Andrew M. Peseski, et al. · Frontiers in Neurology · 17
PDF
Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis
2025 · Anqi Li, Rasha Khatib, et al. · Blood Advances · 11
Does Race Play a Role in Complications and Outcomes of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms?
2021 · Andrew M. Peseski, Antoine N. Saliba, et al. · Hematology/Oncology and Stem Cell Therapy · 8
PDF
Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients
2025 · Douglas Tremblay, Amica Ko, et al. · Blood · 3
PDF
An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county
2024 · Andrew M. Peseski, Sargam Kapoor, et al. · Research and Practice in Thrombosis and Haemostasis · 2
Qualitative comparison of perioperative anticoagulation management guidelines across US institutions
2025 · Ishan J. Tatake, Rishabh Singh, et al. · Thrombosis Research · 1
Anticoagulation in malignancy: the patient who bleeds and clots simultaneously
2025 · Sargam Kapoor, Andrew M. Peseski, et al. · Hematology · 1
Multimodal quality improvement project on reducing hospital perioperative thromboembolic events (Patient Safety Indicator-12)
2025 · Andrew Michael Peseski, Christopher J Vail, et al. · BMJ Open Quality · 1
PDF
Comparative Analysis of Perioperative Anticoagulation Management Guidelines across U.S. Institutions
2024 · Rishabh Singh, Jacob Cogan, et al. · Blood · 1
PDF
The complexity of "provoked" venous thromboembolism: one treatment plan does not fit all Commentary on the HI-PRO Trial.
2026 · Andrew Peseski, Sargam Kapoor, et al. · Blood Advances
Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis
2026 · Douglas Tremblay, Amica Kurniati Ko, et al. · Blood Advances
HTRS2025.P1.44 Comparative Analysis of Perioperative Management of Antiplatelet Agent Guidelines across US Institutions
2025 · Ming Y. Lim, Jacob C. Cogan, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
Comparative analysis of perioperative management of antiplatelet agent guidelines across US institutions
2025 · Ming Y. Lim, Jacob C. Cogan, et al. · Thrombosis Research
64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
2025 · Rishabh Singh, Ishan J. Tatake, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
Imaging Predictors of Intracerebral Hemorrhage in Patients with Brain Tumors Treated with Anticoagulation
2024 · Rani Barnea, Jonathan Naftali, et al. · Blood
PDF
Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
2024 · Rishabh Singh, Ishan J Tatake, et al. · Blood
PDF
Treatment Complications of Venous Thromboembolism in Patients with Central Nervous System Tumors
2023 · Andrew M. Peseski, Thomas L. Ortel, et al. · Blood
PDF
Role of ethnicity in thrombotic and hemorrhagic complications of myeloproliferative neoplasms.
2019 · Andrew Peseski, Antoine Saliba, et al. · Journal of Clinical Oncology
Works count: 19
Citation count: 85
H-index: 4
I10-index: 3
Year
Topic
Type